Peter Ghosh

This inventor holds 23 USPTO granted patents and 11 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Connective Tissue Engineering. Top assignees: Mesoblast, Inc, Paradigm Health Sciences Pty Ltd, Proteobioactives Pty Ltd. Active years: 1992-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Ghosh. Retrieved from https://idiyas.com/inventor/peter-ghosh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 11)

% Patents Active = 87.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 4)

Average Co-Inventor Count = 1.4

ph-index = 4

Forward Citations = 91(Granted Patents)

Company Filing History:

Paradigm Health Sciences Pty Ltd

patents

4 out of 4

Proteobioactives Pty Ltd

patents

4. 2 out of 4

Arthropharm Pty. Ltd.

patents

5. 2 out of 2

Institute of Nutraceutical Research Pty Ltd.

patents

6. 1 out of 1

Anthropharm Pty. Limited

patent

7. 1 out of 1

Emu Products Western Australia Pty. Ltd.

patent

Years Active: 1992-2026

Loading Chart...

Areas of Expertise:

Connective Tissue

Bone Marrow Edema

Pain Management

Anti-Inflammatory

Progenitor Cells

Nutraceuticals

Skin Treatment

Invertebral Discs

Polysulfated Polysaccharides

Rheumatic Disease

Topical Compositions

Tissue Repair

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12558382 - Repair and/or reconstruction of invertebral discs (2026-02-24),

2. 12220433 - Methods of generating, repairing and/or maintaining connective tissue in vivo (2025-02-11),

3. 11911413 - Methods and compositions for the treatment of pain and/or inflammation (2024-02-27),

4. 11406660 - Treatment of bone marrow edema (OEDEMA) with polysulfated polysaccharides (2022-08-09),

5. 10688134 - Methods of treating or preventing respiratory conditions (2020-06-23),

6. 10610542 - Treatment of bone marrow edema (oedema) with polysulfated polysaccharides (2020-04-07),

7. 10609922 - Protection of progenitor cells and regulation of their differentiation (2020-04-07),

8. 10596199 - Methods of treating or preventing rheumatic disease (2020-03-24),

9. 10028979 - Methods of treating or preventing respiratory conditions (2018-07-24),

10. 9974812 - Methods of treating or preventing rheumatic disease (2018-05-22),

11. 9888679 - Protection of progenitor cells and regulation of their differentiation (2018-02-13),

12. 9861657 - Treatment of bone marrow edema (oedema) with polysulfated polysaccharides (2018-01-09),

13. 9381216 - Methods of generating, repairing and/or maintaining connective tissue in vivo (2016-07-05),

14. 9265796 - Methods of treating or preventing rheumatic disease (2016-02-23),

15. 9101650 - Treatment of bone marrow edema (oedema) with polysulfated polysaccharides (2015-08-11),

Title: Peter Ghosh: A Pioneer in Connective Tissue Innovations

Introduction

Peter Ghosh, based in Fairlight, Australia, is a distinguished inventor with a remarkable portfolio of 22 patents. His contributions to the field of biotechnology, particularly in the generation and maintenance of connective tissue, underscore his dedication to advancing medical science.

Latest Patents

Ghosh's recent patents reflect his innovative approaches to treatment and pain management. One notable invention details methods for generating, repairing, and maintaining connective tissue, emphasizing cartilage tissue restoration. This invention aims to address diseases caused by the degradation and inflammation of connective tissues, offering new hope for patients suffering from such conditions. Another significant patent focuses on pharmaceutical compositions designed for oral administration, containing coxibs in combination with pentosan polysulfate. These formulations are effective in treating pain and inflammation and potentially improve patient quality of life.

Career Highlights

Throughout his career, Peter Ghosh has been associated with prominent companies such as Mesoblast, Inc. and Paradigm Health Sciences Pty Ltd. His work at these organizations has been instrumental in pushing the boundaries of medical research, particularly in regenerative medicine and therapeutic solutions.

Collaborations

Ghosh has collaborated with notable professionals in his field, including Silviu Itescu and David Cullis-Hill. Their collective expertise has facilitated the development of innovative treatments that stand at the forefront of medical advancements.

Conclusion

Peter Ghosh’s contributions to biotechnology through his inventions and patents demonstrate a profound commitment to improving human health. His work not only advances scientific understanding but also holds the potential to transform the lives of many patients globally. As research continues to evolve, Ghosh's innovations will undoubtedly play a crucial role in the future of medical therapies.

Profile summary based on public USPTO records.